IP Library Granted Patent US 8,975,054
Granted Patent B2
US 8,975,054 · App. 12/723,264 · Granted Mar 10, 2015

Microorganisims used to synthesize oligosaccharides

Inventor: Eric Samain (Gieres, FR)
Assignee: Centre National de la Recherche Scientifique (CNRS)
C12N9/1081C12N1/20C12P19/04C12P19/26C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,054
App. No.
12/723,264
Granted
Mar 10, 2015
Kind
B2
Abstract

The present invention relates to the enzymatic synthesis of oligosaccharides, particularly, sialylated oligosaccharides comprising the carbohydrate moeities of the gangliosides GM3, GD3, and GT3.

Claims (9)

1. An Escherichia coli microorganism comprising a heterologous gene encoding a bifunctional Campylobacter jejuni sialyltransferase polypeptide that catalyzes the transfer of a sialyl moiety from an activated sialic acid molecule to lactose to form Neu5Acα-3Galβ-4Glc, wherein the Escherichia coli microorganism lacks Neu5Ac aldolase activity and β galactosidase activity, and wherein the heterologous gene encoding a bifunctional Campylobacter jejuni sialyltransferase has at least 95% sequence identity to a sequence selected from the group consisting of SEQ ID NOs: 1, 2, 3, and 4, and wherein the microorganism is LacY+ and NanT+ allowing active transport of lactose and sialylic acid.

2. A cell culture medium comprising lactose and Neu5Ac wherein the Neu5Ac is present at or continuously supplied to maintain a concentration between 2 mM and 60 mM, and an Escherichia coli microorganism comprising a heterologous gene encoding a bifunctional Campylobacter jejuni sialyltransferase polypeptide that catalyzes the transfer of a sialyl moiety from an activated sialic acid molecule to lactose to form Neu5Acα-3Galβ-4Glc, wherein the microorganism lacks Neu5Ac aldolase activity and β galactosidase activity, and wherein the heterologous gene encoding a bifunctional Campylobacter jejuni sialyltransferase has at least 95% sequence identity to a sequence selected from SEQ ID NOs: 1, 2, 3 and 4.

3. The cell culture medium of claim 2 , wherein the lactose is present at or continuously supplied to maintain a concentration between 1 mM and 30 mM.

4. The Escherichia coli microorganism of claim 1 , which further comprises a heterologous gene encoding a cytidine monophospho-(CMP)-sialic acid synthetase.

5. The Escherichia coli microorganism of claim 4 , wherein the heterologous gene encoding the CMP-sialic acid synthetase is the gene for CMP-sialic acid synthetase from Neisseria meningitis.

6. The Escherichia coli microorganism of claim 1 , wherein the heterologous gene encoding a bifunctional Campylobacter jejuni sialyltransferase is selected from the group consisting of SEQ ID NOs: 1, 2, 3, and 4.

7. The Escherichia coli microorganism of claim 1 , wherein the heterologous gene encoding a bifunctional Campylobacter jejuni sialyltransferase is selected from the group consisting of SEQ ID NOs: 1, 2, 3, 4, and any conservative substitution of a nucleotide of SEQ ID NOs: 1, 2, 3 or 4.

8. The cell culture medium of claim 2 , wherein the Neu5Ac is present at or continuously supplied to maintain a concentration of about 6 mM.

9. The cell culture medium of claim 3 , wherein the lactose is present at or continuously supplied to maintain a concentration of about 3 mM.

Continuity (3)
Division 11447287 · Jun 6, 2006
Provisional Application 60690837 · Jun 16, 2005
Related Publication 20100267660A1 · Oct 21, 2010